page_banner

product

5-Fluorouracil(CAS# 51-21-8)

Chemical Property:

Formulae hypotheticae C4H3FN2O2
Molar Mass 130.08
Densitas 1.4593 (aestima)
Liquefactio Point 282-286 °C (decl.)
Boling Point 190-200°C/0.1mmHg
Aqua Solubility 12.2 g/L 20 C
Solubilitas Leviter solutum in ethanol. Prope insolubile est in solutione chloroformi et in sodium hydroxide resolutum.
Aspectus Album aut album-sicut crystallinum pulveris
Color album
Merck 14,4181
BRN 127172
pKa pKa 8.0±0.1 (H2O) (incerta); 3.0±0.1(H2O)
PH 4.3-5.3 (10g/l, H2O, 20℃)
Repono Condition 2-8°C
Stabilitas Stabulum. Lux sensibilis. Combustible. Compatible cum validis oxidizing agentium, bases fortes.
Sensitiva Air Sensitiva
Index refractivus 1.542
MDL MCD00006018
Physica et Chemical Properties punctum liquefaciens 282-286°C (decl.)
solubility H2O: 10 mg/mL, clarum

forma pulveris

color albus

aqua solubility 12.2g/L 20 c
Sensitiva Air
merck 14,4181
BRN 127172

Usus Cancer ad systema digestivum, cancer capitis et colli, cancer gynecologicus, cancer pulmonis, cancer jecoris, cancer vesicae et curatio cancer cutis

Product Detail

Product Tags

Periculum Codes R22 - noxium absorptus
R20/21/22 - Inspiratio noxia, in contactu cum cute et absorpta.
R52 - Noxia organismi aquatilium
R25 - Toxicus absorptus
Salus Descriptio S36 - Apta indumenta tutela gere.
S36/37 - indumentis tutelae idoneis gere et caestus.
S36/37/39 - Vestis tutelae, chirothecae et oculi/faciei tutelam idoneam induere.
S22 — Pulverem noli spirare.
S45 - In casu accidentis vel si bene sentis, consilium medicinae statim quaere (litteras cum fieri potest demonstrare).
S26 - In contactu cum oculis, statim cum aqua multa ablue et consilium quaere medicinae.
Consociatione Nationum IDs UN 2811 6.1/PG 3
WGK Germania 3
RTECS YR0350000
FLUKA BRAND F CODES 10-23
TSCA T
HS Code* 29335995
Aleam Nota Irritant / Highly Toxicus
Periculum Classis 6.1
Stipare Group III
Toxicity LD50 viva voce in Rabbit: 230 mg/kg

 

Introductio

Hoc productum primum in nucleotides 5-fluoro-2-deoxyuracillorum convertitur in corpore, quod synthasin thyminum nucleotidis vetat et conversionem deoxyuracillorum nucleotidum in deoxythyminum nucleotides impedit, ita inhibens DNA biosynthesin. Praeterea, impediendo incorporationem acidi uracil et rotici in RNA, effectus inhibendi synthesin RNA obtinetur. Hoc productum est cyclum cella specifica medicamento, maxime inhibuit cellas S phase.


  • Priora:
  • Next:

  • Epistulam tuam hic scribe et mitte nobis